JPS55130920A - Liposome particle containing virus or bacteria antigen subunit - Google Patents
Liposome particle containing virus or bacteria antigen subunitInfo
- Publication number
- JPS55130920A JPS55130920A JP3764480A JP3764480A JPS55130920A JP S55130920 A JPS55130920 A JP S55130920A JP 3764480 A JP3764480 A JP 3764480A JP 3764480 A JP3764480 A JP 3764480A JP S55130920 A JPS55130920 A JP S55130920A
- Authority
- JP
- Japan
- Prior art keywords
- particle containing
- containing virus
- liposome particle
- antigen subunit
- bacteria antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894006 Bacteria Species 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000002502 liposome Substances 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/024,144 US4199565A (en) | 1979-03-26 | 1979-03-26 | Liposome particle containing viral or bacterial antigenic subunit |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS55130920A true JPS55130920A (en) | 1980-10-11 |
Family
ID=21819075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3764480A Pending JPS55130920A (en) | 1979-03-26 | 1980-03-26 | Liposome particle containing virus or bacteria antigen subunit |
Country Status (5)
Country | Link |
---|---|
US (1) | US4199565A (ja) |
EP (1) | EP0017557A3 (ja) |
JP (1) | JPS55130920A (ja) |
CA (1) | CA1151543A (ja) |
DK (1) | DK127380A (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60155119A (ja) * | 1984-01-24 | 1985-08-15 | Toubishi Yakuhin Kogyo Kk | 抗体産生誘起物質 |
WO1993017702A1 (en) * | 1992-03-03 | 1993-09-16 | Daiichi Pharmaceutical Co., Ltd. | Oral vaccine |
JPH06504759A (ja) * | 1990-06-29 | 1994-06-02 | カイロン コーポレイション | リポソーム含有ワクチン組成物 |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3173713D1 (en) * | 1980-09-05 | 1986-03-20 | Frappier Armand Inst | Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane |
US4882165A (en) * | 1981-11-09 | 1989-11-21 | The Regents Of The University Of California | Light sensitive liposomes |
US4429008B1 (en) | 1981-12-10 | 1995-05-16 | Univ California | Thiol reactive liposomes |
NL8202527A (nl) * | 1982-06-22 | 1984-01-16 | Univ Utrecht | Vaccins tegen door bacterien met kapsel-polysacchariden verwekte ziekten en werkwijze voor het bereiden daarvan. |
DE3412793A1 (de) * | 1984-04-05 | 1985-10-17 | Basotherm GmbH, 7950 Biberach | Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
DE3433609A1 (de) * | 1984-04-11 | 1986-03-20 | Karl Prof. Dr.med. 7302 Ostfildern Theurer | Weiterentwicklung des verfahrens zur herstellung von diaetmilch und -sahne |
US5897873A (en) * | 1984-04-12 | 1999-04-27 | The Liposome Company, Inc. | Affinity associated vaccine |
CA1261264A (en) * | 1984-11-29 | 1989-09-26 | Shigeo Suzuki | Immunopotentiating agents and method |
US5545412A (en) * | 1985-01-07 | 1996-08-13 | Syntex (U.S.A.) Inc. | N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor |
US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US4837380A (en) * | 1985-09-30 | 1989-06-06 | Regents Of University Of California | Liposome-calcitonin preparation |
US4790987A (en) * | 1985-11-15 | 1988-12-13 | Research Corporation | Viral glycoprotein subunit vaccine |
LU86736A1 (fr) * | 1987-01-15 | 1988-08-23 | Univ Bruxelles | Liposomes sensibilises a des molecules antigeniques de parasites intracellulaires,procede pour les preparations et leurs applications comme moyens de diagnostic et comme agents d'immunisation |
US5110794A (en) * | 1987-01-30 | 1992-05-05 | Abbott Laboratories | Method of immunization with partially cationized substances and said partially cationized substances |
US5026557A (en) * | 1987-09-09 | 1991-06-25 | The Liposome Company, Inc. | Adjuvant composition |
WO1989005633A1 (en) * | 1987-12-19 | 1989-06-29 | Laboratorium Für Experimentelle Chirurgie | Anti-viral therapeutic composition |
US5194425A (en) * | 1988-06-23 | 1993-03-16 | Anergen, Inc. | Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
US5260422A (en) * | 1988-06-23 | 1993-11-09 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
US5130297A (en) * | 1988-06-23 | 1992-07-14 | Anergen, Inc. | Conjugates useful in ameliorating autoimmunity MHC-II-peptide |
US5468481A (en) * | 1988-06-23 | 1995-11-21 | Amergen, Inc. | MHC class II-peptide conjugates useful in ameliorating autoimmunity |
NZ230424A (en) * | 1988-08-25 | 1992-05-26 | Liposome Co Inc | Liposomal composition comprising an externally disposed antigen |
EP0440742B1 (en) * | 1988-10-27 | 1997-01-15 | The Regents Of The University Of Minnesota | Liposome immunoadjuvants containing il-2 |
US5709879A (en) * | 1990-06-29 | 1998-01-20 | Chiron Corporation | Vaccine compositions containing liposomes |
IE912535A1 (en) * | 1990-07-27 | 1992-01-29 | Res Dev Foundation | Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens |
DE69229703T2 (de) * | 1991-05-08 | 2000-04-27 | Schweiz Serum & Impfinst | Wiederhergestellte Influenza-Virosomen mit immunostimulierenden und immunoverstärkenden Eigenschaften und diese enthaltende Impfstoffe |
AU665762B2 (en) * | 1991-05-13 | 1996-01-18 | Regents Of The University Of California, The | Liposomal polysaccharide vaccines |
DE4136553A1 (de) * | 1991-11-06 | 1993-05-13 | Biotechnolog Forschung Gmbh | Impfstoff gegen schleimhauterreger und herstellungsverfahren |
US6207185B1 (en) | 1996-03-22 | 2001-03-27 | Bio-Sphere Technology | Method for inducing a systemic immune response to an HIV antigen |
US6015576A (en) * | 1997-08-29 | 2000-01-18 | Bio-Sphere Technology, Inc. | Method for inducing a systemic immune response to an antigen |
US6117449A (en) * | 1996-03-22 | 2000-09-12 | Bio-Sphere Technology, Inc. | Method for inducing a systemic immune response to a hepatitis antigen |
US6749831B1 (en) * | 1997-05-16 | 2004-06-15 | Medical Defense Technology, Llc | Vaccine against lipopolysaccharide core |
PL1909830T3 (pl) * | 2005-08-02 | 2012-02-29 | Novartis Vaccines And Diagnostics S R L | Ograniczenie oddziaływania pomiędzy olejem w adiuwancie a środkiem powierzchniowo czynnym w antygenie |
WO2009090650A2 (en) * | 2008-01-16 | 2009-07-23 | Ben-Gurion University Of The Negev Research And Development Authority | Vaccine for alzheimer's disease |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1502774A (en) * | 1974-06-25 | 1978-03-01 | Nat Res Dev | Immunological preparations |
US4117113A (en) * | 1974-06-25 | 1978-09-26 | National Research Development Corporation | Immunological preparations |
CH588887A5 (ja) * | 1974-07-19 | 1977-06-15 | Battelle Memorial Institute | |
US4148876A (en) * | 1975-09-29 | 1979-04-10 | Burroughs Wellcome Co. | Biological preparations |
GB1564500A (en) | 1975-09-29 | 1980-04-10 | Wellcome Found | Biological preparations |
US4201767A (en) * | 1978-11-08 | 1980-05-06 | Merck & Co., Inc. | Viral liposome particle |
-
1979
- 1979-03-26 US US06/024,144 patent/US4199565A/en not_active Expired - Lifetime
-
1980
- 1980-03-17 CA CA000347793A patent/CA1151543A/en not_active Expired
- 1980-03-25 DK DK127380A patent/DK127380A/da not_active Application Discontinuation
- 1980-03-25 EP EP80400395A patent/EP0017557A3/en not_active Withdrawn
- 1980-03-26 JP JP3764480A patent/JPS55130920A/ja active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60155119A (ja) * | 1984-01-24 | 1985-08-15 | Toubishi Yakuhin Kogyo Kk | 抗体産生誘起物質 |
JPH06504759A (ja) * | 1990-06-29 | 1994-06-02 | カイロン コーポレイション | リポソーム含有ワクチン組成物 |
WO1993017702A1 (en) * | 1992-03-03 | 1993-09-16 | Daiichi Pharmaceutical Co., Ltd. | Oral vaccine |
Also Published As
Publication number | Publication date |
---|---|
EP0017557A3 (en) | 1981-05-27 |
DK127380A (da) | 1980-09-27 |
EP0017557A2 (en) | 1980-10-15 |
CA1151543A (en) | 1983-08-09 |
US4199565A (en) | 1980-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS55130920A (en) | Liposome particle containing virus or bacteria antigen subunit | |
IL68749A (en) | Modified antigens,their preparation and vaccines containing them | |
JPS5663995A (en) | Nontransit virus | |
DE3360433D1 (en) | Oxime ethers, process for their preparation, agents containing the oxime ethers and their use | |
JPS5566520A (en) | Virulent liposome particle | |
IL65835A0 (en) | Protozoal antigen,its preparation and vaccine containing it | |
JPS5612319A (en) | Cholera vaccine | |
IL65496A0 (en) | Protozoal antigen,its preparation and vaccine containing it | |
IL60140A0 (en) | Novel 3-vinyl-cephalosporins and their preparation | |
JPS55143254A (en) | Envelop | |
DE3160264D1 (en) | Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines | |
GB2048068B (en) | Vaccines containing antigens from t cruzi organisms | |
DE3069946D1 (en) | Bottle | |
GB2066865B (en) | Permanent-waving solution | |
EP0012611A3 (en) | Electrophotographic elements and the preparation thereof | |
GB2039599B (en) | Security container | |
EP0043937A3 (en) | Anthraquinone-azo compounds, their preparation and their use | |
GB2045256B (en) | Immunological preparations | |
IE801504L (en) | Preparation of azetidin-2-ones. | |
JPS55113427A (en) | Air thermos | |
IE792122L (en) | Viral liposome particles | |
GB2052430B (en) | Handling bags or envelopes | |
AU534625B2 (en) | Clostridal vaccine | |
CA46055S (en) | Bottle | |
CA46056S (en) | Bottle |